Patient Immunotherapy Summit: Lung Cancer Brief January 9, 2024January 9, 2024 Max Mallet Thomas Urban Marron, MD, PhD, Icahn School of Medicine at Mount Sinai and CRI Clinical Innovator, is an authority in the immunotherapy space with backgrounds both in research and medicine. CRI is proud to have him speak during this summit about lung cancer, a disease that is diagnosed in over 2M new patients every year worldwide. Dr. Marron contributes towards our greater understanding of lung cancer and novel treatments for the disease. Read more: Post navigation Patient Immunotherapy Summit: I’m the Answer to Cancer™ Barry’s Patient Story Read Story Patient Immunotherapy Summit: Hot Topics and Trends in Cancer Immunotherapy Read Story